Investment Trusts

Parent company accounts for half the trust's assets

Some firms will 'grow through the crisis'

J.P. Morgan Cazenove turns 'neutral' on investment trust

Outlooks for the biotech sector

Could spell bottom for value, say experts

Follows 'an extended period of underperformance'

'Unique record' to be maintained

'Reliable source of income'

Increases holding to 50.2% of investment trust

98% of intended trading completed by new manager